AI-generated summary
The authors pooled eight randomized trials of children classified as premyopic, testing low-concentration atropine, repeated low-level red-light therapy, and a study-specific lenslet spectacle design. They report that atropine and red light were associated with a smaller myopic shift and reduced axial elongation at 12 months, but certainty was low to very low, and the abstract notes limited replication and insufficient long-term safety evidence.
- Studies included
- 8
- Who or what was studied
- Non-myopic children classified as premyopic, mostly from China with one study from India
- Limits stated in the abstract
- Certainty of evidence was low to very low, with limited replication, incomplete technical and adverse-event reporting, restricted geographic representation, and insufficient long-term safety data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Meta-analysis, Repeated low-level red light, Myopia, Risk of bias, Replication, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.